Dr. Virgil Musta said, during the debate “Monoclonal antibodies – solution in the crisis COVID-19”, organized by DC MEDIA GROUP, who receives this treatment and under what conditions.
–
“These monoclonal antibodies, like antiviral drugs with different action on the virus, are effective in the first week. Up to 10 days. In order to administer these antibodies, we need to quickly detect the disease at the first symptoms so that we can evaluate the patient and “We administer antibodies. From a medical point of view, the administration is a formality. An infusion is made, after which the patient is followed for a few hours and can be discharged. They can also be administered in outpatient conditions,” said Dr. Virgil Musta.
Monoclonal antibody therapy, expensive
“But because it is an expensive therapy, it is important to specify that these antibodies do not replace vaccines. Vaccines are essential to protect you. But there are people who cannot be vaccinated or who have few antibodies after the vaccine and who are at risk of severe evolution if they get sick These are the ones who qualify for the administration of monoclonal antibodies This is happening in our country but also in other countries Nowhere are these antibodies given to anyone under any conditions.
The main condition is that the patient is in the first 7 days of the disease, does not need oxygen. There are conditions that the FDA and EMA have imposed on the administration of these antibodies. Then there are criteria for pathology. We considered that it must have a loaded pathology and, when a larger quantity of antibodies comes, we should make the scheme more flexible “, the doctor added.
Who can benefit from monoclonal antibodies
“Patients with congestive heart failure or recent myocardial infarction can benefit. They can benefit those with lung disease, they can benefit those with neoplasms, but they are in treatment. They have a chance of survival. They can also benefit patients with chronic liver disease, such as cirrhosis of the liver, not just any hepatitis, but only severe forms, of course, those who are obese and type 1 or insulin-dependent diabetics, because they have severe forms of the disease. those with organ transplants, and HIV patients, as a last resort, are those over the age of 65, ie those at high risk of developing a severe form of the disease and who accumulate pathologies loaded at this age.
It should be noted that in the process of administering antibodies, family doctors have a particularly important role. We, as specialists, do not know the chronic pathology of the patient. I recommend them to make a map of the people who would fit, and if they become infected, to recommend them immediately for this treatment. That’s what patients need to know. If you get an infection or have symptoms of COVID-19, get tested quickly. Because, unfortunately, severe forms are tested late, when the symptoms are intense or when they can no longer breathe. These monoclonal antibodies are not effective in these phases, “concluded Virgil Musta.
– .
